US regulator rejects Novartis heart failure drugReuters UKZURICH (Reuters) – U.S. health regulators turned down an application to approve Novartis’ experimental heart failure drug due to insufficient evidence that it improves symptoms, the Swiss drugmaker said on Friday. Novartis said in a statement the Food and …and more …Read Full Story
US regulator rejects Novartis heart failure drug - Reuters UK
Real Estate of Cebu
